Acceptability of LNS for Infants and Young Children in Guatemala
Acceptability of Lipid-based Nutrient Supplements (LNS) for Infants and Young Children in Guatemala
1 other identifier
observational
43
1 country
1
Brief Summary
This study aims to assess the acceptability of lipid-based nutrient supplements (LNS) for use as nutritional supplements for infants and young children in Guatemala. The study was conducted in three phases. Phase 1 was a test-feeding to compare the acceptability of two different flavors of LNS (peanut and cinnamon) in infants and young children and their mothers or caregivers in terms of taste, smell and texture, as well as amount of the test-dose consumed. In Phase 2, children in the Phase 1 trial received a 2-week supply of one of the LNS products, which they consumed daily in their homes for 14 days under real-life conditions. Direct observation of supplement use and in-depth interviews with mothers, caregivers and health staff providing services in communities will be part of this phase too. In Phase 3, focus group discussions (FGD) were held with participants (mothers and caregivers) as well as with health staff providing services in communities to discuss different aspects of infant and child feeding and best ways for the LNS product to be used in the context of Guatemala. We hypothesized that both flavors of LNS would be accepted by Guatemalan infants and young children children and their mothers or caregivers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 18, 2010
CompletedFirst Posted
Study publicly available on registry
June 22, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedJanuary 29, 2018
January 1, 2018
2 months
June 18, 2010
January 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
amount of LNS consumed
Amount of LNS consumed in the test trial in grams
2 weeks
time of consumption
Avg how long it takes to eat the LNS mins
2 weeks
amount of LNS sachets consumed in the home-use trial
\# of sachets consumed
2 weeks
Secondary Outcomes (1)
qualitative assessment of mothers and caregivers opinions
2 weeks
Study Arms (2)
LNS-regular
Lipid-based nutrient supplement, regular (peanut) flavor
LNS-cinnamon
Lipid-based nutrient supplement, cinnamon flavor
Interventions
Infants and young children will receive 10 g of LNS for test trial during 3 consecutive days (crossover design) and thereafter, 20 g per day for 14 days.
Eligibility Criteria
\- Children 6-18 months of age.
You may qualify if:
- Children 6-18 months of age.
- Consuming solid foods for at least the past 30 days.
- Apparently healthy and not presently suffering from an acute illness (e.g., fever, diarrhea, acute respiratory tract infection).
- No known allergy to peanuts or other food products (as reported on the screening questionnaire by the mother/primary caregiver).
- Not severely malnourished \[mid-upper arm circumference (MUAC) \> 115 mm\].
- Maternal/caregiver willingness to feed the infant with LNS over a maximum 3 test days, and over the 2 week home-use period, and report on his/her consumption and reactions and practices for daily use. Willingness to participate in discussion groups.
- Planning to remain in study area for at least the following three weeks.
You may not qualify if:
- Children under 6 months of age.
- All subjects with known peanut, soy or milk allergies.
- In poor health or ill at the time of recruitment.
- Severely malnourished children \[mid-upper arm circumference (MUAC) \< 115 mm\].
- Not willing to participate in study procedures.
- Leaving the study area in the following three weeks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Davislead
- FHI 360collaborator
Study Sites (1)
Fundacion de la Caficultura para el Dessarrollo Rural (FUNCAFE)
Mazatenango, Departamento de Suchitepéquez, zona 1, Guatemala
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathryn G Dewey, PhD
University of California, Davis
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2010
First Posted
June 22, 2010
Study Start
May 1, 2010
Primary Completion
July 1, 2010
Study Completion
November 1, 2010
Last Updated
January 29, 2018
Record last verified: 2018-01